Search Within

Christopher A Famulare

  1. "Noushin Rahnamay Farnoud"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
Groups
  1. Adult Leukemia (14)
  2. Center for Hematologic Malignancies (14)
  3. Department of Medicine (14)
  4. Hematologic Malignancies, Division of (14)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Noushin Rahnamay Farnoud (14)
  2. Raajit Rampal (9)
  3. Ross Levine (9)
  4. Elli Papaemmanuil (8)
  5. Minal Patel (8)
  6. Martin Tallman (7)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2018 (6)
  6. 2017 (1)
Publications
  1. Blood (8)
  2. Blood Advances (2)
  3. American Journal of Hematology (1)
  4. Cancer Discovery (1)
  5. Clinical Cancer Research (1)
  6. Nature (1)
Publishers
  1. American Society of Hematology (10)
  2. American Association for Cancer Research (2)
  3. John Wiley & Sons, Inc. (1)
  4. Nature Publishing Group (1)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms
    Journal Article

    Marinaccio, C.; Suraneni, P.; Celik, H.; Volk, A.; Wen, Q. J.; Ling, T.; Bulic, M.; Lasho, T.; Koche, R. P.; Famulare, C. A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The genetic architecture of myeloproliferative neoplasms-blast phase (MPN-BP) stem cells
    Meeting Abstract

    Wang, X.; Rampal, R. K.; Hu, C. S.; Farnoud, N.; Famulare, C.; Patel, M. A.; McGovern, E.; Hoffman, R.
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial
    Journal Article

    Gangat, N.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Rademaker, A.; Fought, A. J.; Frankfurt, O.; Altman, J. K.; Wen, Q. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Tripodi, J.; Najfeld, V.; Petersen, B.; Rampal, R. K.; Farnoud, N.; Famulare, C.; Mascarenhas, J.; Hoffman, R.
    Blood (2018)

    Fulltext@MSK | Save
  • TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Talati, C.; Desai, P.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Sallman, D. A.; Lancet, J. E.; Roboz, G. J.; Sweet, K. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Alisertib (MLN8237), an oral selective inhibitor of aurora kinase A, has clinical activity and restores GATA1 expression in patients with myelofibrosis
    Meeting Abstract

    Gangat, N.; Stein, B. L.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Frankfurt, O.; Altman, J. K.; Wen, J. Q.; Farnoud, N.; more...
    Blood (2018)

    Fulltext@MSK | Save